SERPINE1 and neoplasm: Consistently, our findings revealed that blocking of PAI-1 bioactivity using a small molecule inhibitor resulted in significant immunostimulation of the tumor microenvironment, thereby overcoming the resistance of the melanoma to MitoX insult (Figure 5).